Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?

Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

Reprod Biol Endocrinol. 2013 Jun 27;11:58. doi: 10.1186/1477-7827-11-58.

2.

Hypoandrogenism in association with diminished functional ovarian reserve.

Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

Hum Reprod. 2013 Apr;28(4):1084-91. doi: 10.1093/humrep/det033. Epub 2013 Feb 20.

PMID:
23427231
3.

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

J Assist Reprod Genet. 2013 Jan;30(1):49-62. doi: 10.1007/s10815-012-9890-z. Epub 2012 Dec 5.

4.

Some aspects of interactivity between endocrine and immune systems required for successful reproduction.

Weghofer A, Himaya E, Kushnir VA, Barad DH, Lazzaroni-Tealdi E, Yu Y, Wu YG, Gleicher N.

Reprod Biol Endocrinol. 2015 Apr 11;13:29. doi: 10.1186/s12958-015-0020-5.

5.

Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.

Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N.

J Ovarian Res. 2015 Jul 9;8:45. doi: 10.1186/s13048-015-0175-x.

6.

Hirsutism and virilism in women.

Kirschner MA.

Spec Top Endocrinol Metab. 1984;6:55-93. Review.

PMID:
6084314
7.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES).

Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.

PMID:
26509855
8.

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.

Hum Reprod. 2015 Oct;30(10):2376-86. doi: 10.1093/humrep/dev195. Epub 2015 Aug 12.

PMID:
26269538
9.

Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.

Stanczyk FZ, Saxena T, Lobo RA.

J Steroid Biochem Mol Biol. 2014 Jan;139:73-7. doi: 10.1016/j.jsbmb.2013.09.015. Epub 2013 Oct 10.

PMID:
24121067
10.

Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.

Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.

J Clin Endocrinol Metab. 2011 Mar;96(3):623-31. doi: 10.1210/jc.2010-0130. Epub 2010 Dec 22.

PMID:
21177795
11.

Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.

Schufreider A, McQueen DB, Lee SM, Allon R, Uhler ML, Davie J, Feinberg EC.

Hum Reprod. 2015 Nov;30(11):2686-92. doi: 10.1093/humrep/dev220. Epub 2015 Sep 6.

PMID:
26345686
12.

The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.

Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2003 May;58(5):601-11.

PMID:
12699442
13.

Androgens and the menopause; a study of 40-60-year-old women.

Bancroft J, Cawood EH.

Clin Endocrinol (Oxf). 1996 Nov;45(5):577-87.

PMID:
8977755
14.

Premature ovarian failure: steroid synthesis and autoimmunity.

Doldi N, Belvisi L, Bassan M, Fusi FM, Ferrari A.

Gynecol Endocrinol. 1998 Feb;12(1):23-8.

PMID:
9526706
15.

Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.

Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnston DG, Franks S.

Clin Endocrinol (Oxf). 1991 Sep;35(3):253-7.

PMID:
1742883
16.

Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.

Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.

Exp Clin Endocrinol Diabetes. 2007 Jun;115(6):380-6.

PMID:
17701884
17.

Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.

Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS.

J Clin Endocrinol Metab. 2009 Jun;94(6):1973-8. doi: 10.1210/jc.2008-2583. Epub 2009 Mar 24.

PMID:
19318449
18.

[Thyroid, ovarian and adrenal antibodies in female patients with autoimmune thyroiditis].

Sterzl I, Nováková D, Vavrejnová V, Zamrazil V.

Cas Lek Cesk. 1997 Apr 16;136(8):249-52. Czech.

PMID:
9264869
19.
20.

Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility.

Sills ES, Genton MG, Perloe M, Schattman GL, Bralley JA, Tucker MJ.

J Obstet Gynaecol Res. 2001 Jun;27(3):163-8.

PMID:
11561833

Supplemental Content

Support Center